BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5324310)

  • 1. [On the treatment of hepatobiliary diseases with phytopharmaceutics].
    Glitsch HW
    Hippokrates; 1965 Sep; 36(18):726-9. PubMed ID: 5324310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicotherapeutic studies on a new hepatobiliary capsule preparation].
    Medgyesi G
    Med Welt; 1966 Jul; 31():1623-6. PubMed ID: 5929031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trials with dibilene therapy].
    Bénazet C; Breton J
    J Med Bord; 1965 May; 142(5):859-67. PubMed ID: 5830455
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)].
    Bode JC; Strohmeyer G
    Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
    Barbi G
    Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV; Lebedeva OI
    Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oragallin purum, a new choleretic].
    Dierel HL
    Wien Med Wochenschr; 1965 Jul; 115(30):613-5. PubMed ID: 5319876
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of a hepato-biliary medication].
    Etaix JP
    J Med Lyon; 1969 Feb; 50(158):223-6. PubMed ID: 4181199
    [No Abstract]   [Full Text] [Related]  

  • 9. [In process].
    Vollmer H
    Med Monatsschr Pharm; 2017 Mar; 40(3):131. PubMed ID: 29952486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of liver diseases in the hands of the general practitioner].
    Blank K
    Z Allgemeinmed; 1969 Apr; 45(11):525-7. PubMed ID: 5785113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of an hepatobiliary analeptic agent].
    Chapuy H; Jeune M; Sambin P; Girard M
    J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials of an association of a choleretic (1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride), (Rec 14-0127) and phenolphthalein and belladonna extract].
    Pozzi M
    Farmaco Prat; 1969 Oct; 24(10):655-62. PubMed ID: 4902987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on the effects of (3-chlor-pyridazinyl-6-thio)-acetic acid diethylamide (Oragallin)].
    Miyoshi A; Ito M; Nakanishi S; Hajiro T; Takeda T
    Naika Hokan; 1968 Mar; 15(3):77-82. PubMed ID: 5691521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy with choleretics and bile kinetics].
    Ritter U
    Med Monatsschr Pharm; 1984 Apr; 7(4):99-104. PubMed ID: 6717369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amphocholeretic effect of Fumaria officinalis].
    Fiegel G
    Z Allgemeinmed; 1971 Dec; 47(34):1819-20. PubMed ID: 5134143
    [No Abstract]   [Full Text] [Related]  

  • 18. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H
    Wien Med Wochenschr; 1972 Apr; 122(14):187-90. PubMed ID: 5014036
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental clinical study of the new product C-29 (Vedrenan) in hepatobiliary processes].
    García García FJ; Velo Vellver JL; Torres Segovia J; Cos Arregui E; Alcala Santaella R
    Rev Esp Enferm Apar Dig; 1972 Mar; 36(5):593-602. PubMed ID: 5013208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.